MedTrace Logo

Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis

NCT03295656 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2020-07-17

No results posted yet for this study

Summary

This study evaluates the ability of contrast-enhanced ultrasound to improve the diagnosis of acute appendicitis in children compared to conventional ultrasound.

Conditions

  • Appendicitis Acute

Interventions

DRUG

Sulfur hexafluoride lipid-type A microspheres

Contrast-enhanced US imaging of the appendix

Sponsors & Collaborators

Principal Investigators

  • Harriet Paltiel, MDCM · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2020-07-15
Completion
2020-07-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295656 on ClinicalTrials.gov